Additional Information

This pediatric-specific panel of genes will help clinicians better understand how to dose medications for each specific patient when genetic differences may play a role in their body’s response to pharmaceuticals. Target populations include:

• Patients being treated for developmental or behavioral disorders: Children and adolescents receiving treatment for mental health conditions such as depression, anxiety, bipolar disorder and ADHD can especially benefit from pharmacogenetic testing. Test results can help optimize medication choices and dosages to enhance efficacy and minimize side effects.
• Patients with cancer: Personalized medication regimens based on genetic profiles can significantly impact treatment success and reduce adverse effects.
• Patients who have had or will have a transplant: Patients who have received organ transplants need precise medication management to prevent organ rejection by managing immunosuppressive therapy and supportive care medications.
• Children with chronic illnesses: Kids with conditions such as epilepsy or heart disease benefit because a better understanding of genetic factors can help clinicians more accurately dose medications for the best potential efficacy.